Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in mice-Reference-Cited by-同舟云学术

Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in mice

Published:2023-01 Issue: Volume:162 Page:105441
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Bhuiyan Mohammad Iqbal H.,Fischer Sydney,Patel Shivani M.,Oft Helena,Zhang Ting,Foley Lesley M.,Zhang Jinwei,Hitchens T. Kevin,Molyneaux Bradley J.,Deng Xianming,Sun Dandan

Funder

U.S. Department of Veterans Affairs

Royal Society

National Institutes of Health

National Institute of Neurological Disorders and Stroke

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference27 articles.

1. Current endovascular treatment of acute ischemic stroke;Bhatia;Mo. Med.,2020

2. WNK-Cab39-NKCC1 signaling increases the susceptibility to ischemic brain damage in hypertensive rats;Bhuiyan;J. Cerebr. Blood Flow Metabol.,2017

3. NF-κB signaling-mediated activation of WNK-SPAK-NKCC1 cascade in worsened stroke outcomes of ang II–hypertensive mice;Bhuiyan;Stroke,2022

4. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension;Brown;Acta Pharmacol. Sin.,2021

5. Preparation of fixed mouse brains for MRI;Cahill;Neuroimage,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of STK39 weakens the MASLD/MASH process by protecting the intestinal barrier;BioScience Trends;2024-06-30

2. Ion transporter cascade, reactive astrogliosis and cerebrovascular diseases;Frontiers in Pharmacology;2024-04-09

3. Experimental Ischemic Stroke Induces Secondary Bihemispheric White Matter Degeneration and Long-Term Cognitive Impairment;Translational Stroke Research;2024-03-15

4. Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders;Molecules;2023-01-31